{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T16:29:45Z","timestamp":1791563385824,"version":"4.3.4"},"reference-count":149,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2021,5,11]],"date-time":"2021-05-11T00:00:00Z","timestamp":1620691200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Statins are among the most widely used drug classes in the world. Apart from their basic mechanism of action, which is lowering cholesterol levels, many pleiotropic effects have been described so far, such as anti-inflammatory and antiatherosclerotic effects. A growing number of scientific reports have proven that these drugs have a beneficial effect on the functioning of the nervous system. The first reports proving that lipid-lowering therapy can influence the development of neurological and psychiatric diseases appeared in the 1990s. Despite numerous studies about the mechanisms by which statins may affect the functioning of the central nervous system (CNS), there are still no clear data explaining this effect. Most studies have focused on the metabolic effects of this group of drugs, however authors have also described the pleiotropic effects of statins, pointing to their probable impact on the neurotransmitter system and neuroprotective effects. The aim of this paper was to review the literature describing the impacts of statins on dopamine, serotonin, acetylcholine, and glutamate neurotransmission, as well as their neuroprotective role. This paper focuses on the mechanisms by which statins affect neurotransmission, as well as on their impacts on neurological and psychiatric diseases such as Parkinson\u2019s disease (PD), Alzheimer\u2019s disease (AD), vascular dementia (VD), stroke, and depression. The pleiotropic effects of statin usage could potentially open floodgates for research in these treatment domains, catching the attention of researchers and clinicians across the globe.<\/jats:p>","DOI":"10.3390\/molecules26102838","type":"journal-article","created":{"date-parts":[[2021,5,11]],"date-time":"2021-05-11T11:30:16Z","timestamp":1620732616000},"page":"2838","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["The Effects of Statins on Neurotransmission and Their Neuroprotective Role in Neurological and Psychiatric Disorders"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2597-463X","authenticated-orcid":false,"given":"Micha\u0142","family":"Kosowski","sequence":"first","affiliation":[{"name":"Department of Internal Medicine and Clinical Pharmacology, Medical University of Silesia, Medyk\u00f3w 18, 40-752 Katowice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4297-8974","authenticated-orcid":false,"given":"Joanna","family":"Smolarczyk-Kosowska","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 40-055 Katowice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"Hachu\u0142a","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Clinical Pharmacology, Medical University of Silesia, Medyk\u00f3w 18, 40-752 Katowice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mateusz","family":"Malig\u0142\u00f3wka","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Clinical Pharmacology, Medical University of Silesia, Medyk\u00f3w 18, 40-752 Katowice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0674-5612","authenticated-orcid":false,"given":"Marcin","family":"Basiak","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Clinical Pharmacology, Medical University of Silesia, Medyk\u00f3w 18, 40-752 Katowice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grzegorz","family":"Machnik","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Clinical Pharmacology, Medical University of Silesia, Medyk\u00f3w 18, 40-752 Katowice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5748-0063","authenticated-orcid":false,"given":"Robert","family":"Pudlo","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 40-055 Katowice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7228-2906","authenticated-orcid":false,"given":"Bogus\u0142aw","family":"Okopie\u0144","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Clinical Pharmacology, Medical University of Silesia, Medyk\u00f3w 18, 40-752 Katowice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,5,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s12016-020-08791-9","article-title":"Anti-inflammatory Action of Statins in Cardiovascular Disease: The Role of Inflammasome and Toll-Like Receptor Pathways","volume":"60","author":"Koushki","year":"2021","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"g4356","DOI":"10.1136\/bmj.g4356","article-title":"Lipid modification and cardiovascular risk assessment for the primary and secondary prevention of cardiovascular disease: Summary of updated NICE guidance","volume":"349","author":"Rabar","year":"2014","journal-title":"BMJ"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/MCA.0000000000000255","article-title":"NLRP3 inflammasome in peripheral blood monocytes of acute coronary syndrome patients and its relationship with statins","volume":"26","author":"Altaf","year":"2015","journal-title":"Coron. Artery Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0021-9150(98)00074-4","article-title":"LPS-induced cytokine pro-duction and expression of LPS-receptors by peripheral blood mononuclear cells of patients with familial hypercholesterolemia and the effect of HMG-CoA reductase inhibitors","volume":"139","author":"Netea","year":"1998","journal-title":"Atherosclerosis"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1136\/bmj.301.6747.309","article-title":"Lowering cholesterol concentrations and mortality: A quantitative review of primary prevention trials","volume":"301","author":"Muldoon","year":"1990","journal-title":"BMJ"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0165-1781(03)00071-4","article-title":"Correlation between serum lipid, lipoprotein concentrations and anxious state, depressive state or major depressive disorder","volume":"118","author":"Huang","year":"2003","journal-title":"Psychiatry Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0924-9338(02)00011-1","article-title":"Cholesterol concentrations in violent and non-violent women suicide attempters","volume":"18","author":"Vevera","year":"2003","journal-title":"Eur. Psychiatry"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jad.2013.11.026","article-title":"Statins use and risk of depression: A systematic review and meta-analysis","volume":"160","author":"Parsaik","year":"2014","journal-title":"J. Affect. Disord."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jad.2019.07.002","article-title":"Do statins have an effect on depressive symptoms? A systematic review and meta-analysis","volume":"257","author":"Yatham","year":"2019","journal-title":"J. Affect. Disord."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0952-3278(91)90035-4","article-title":"Tin and fatty acids in dementia","volume":"43","author":"Corrigan","year":"1991","journal-title":"Prostaglandins, Leukot. Essent. Fat. Acids."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/mds.870090115","article-title":"Increased levels of lipid hydroperoxides in the parkinsonian substantia nigra: An HPLC and ESR study","volume":"9","author":"Dexter","year":"1994","journal-title":"Mov. Disord."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1600-0404.2006.00685.x","article-title":"Cholesterol as a risk factor for Alzheimer\u2019s disease\u2014Epidemiological evidence","volume":"185","author":"Kivipelto","year":"2006","journal-title":"Acta Neurol. Scand. Suppl."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Wei, Q., Wang, H., Tian, Y., Xu, F., Chen, X., and Wang, K. (2013). Reduced Serum Levels of Triglyceride, Very Low Density Lipoprotein Cholesterol and Apolipoprotein B in Parkinson\u2019s Disease Patients. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0075743"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1472-8206.2004.00299.x","article-title":"Chemical, pharmacokinetic and pharmacodynamic properties of statins: An update","volume":"19","author":"Schachter","year":"2004","journal-title":"Fundam. Clin. Pharmacol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1517\/13543784.11.1.125","article-title":"Rosuvastatin: A highly efficacious statin for the treatment of dyslipidaemia","volume":"11","author":"Davidson","year":"2002","journal-title":"Expert Opin. Investig. Drugs."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"117225","DOI":"10.1016\/j.lfs.2019.117225","article-title":"Statins with different lipophilic indices exert distinct effects on skeletal, cardiac and vascular smooth muscle","volume":"242","author":"Irwin","year":"2020","journal-title":"Life Sci."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.4103\/1673-5374.189168","article-title":"Volume transmission and receptor-receptor interactions in heteroreceptor complexes: Understanding the role of new concepts for brain communication","volume":"11","author":"Fuxe","year":"2016","journal-title":"Neural Regen. Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1007\/s11064-015-1574-5","article-title":"Volume Transmission in Central Dopamine and Noradrenaline Neurons and Its Astroglial Targets","volume":"40","author":"Fuxe","year":"2015","journal-title":"Neurochem. Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0165-0173(97)00048-9","article-title":"The emergence of the volume transmission concept","volume":"26","author":"Zoli","year":"1998","journal-title":"Brain Res. Rev."},{"key":"ref_20","first-page":"21","article-title":"The concise guide to pharmacology 2019\/20: G protein-coupled receptors","volume":"176","author":"Alexander","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1474-8673.2006.00376.x","article-title":"Dopamine receptor subtypes in the human pulmonary arterial tree","volume":"26","author":"Ricci","year":"2006","journal-title":"Auton. Autacoid Pharmacol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1177\/153537020322800202","article-title":"Renal Dopamine Receptors and Hypertension","volume":"228","author":"Hussain","year":"2003","journal-title":"Exp. Biol. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/s41398-020-01171-z","article-title":"Dopamine regulates pancreatic glucagon and insulin secretion via adrenergic and dopaminergic receptors","volume":"11","author":"Aslanoglou","year":"2021","journal-title":"Transl. Psychiatry"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.2174\/138161210791516387","article-title":"Pharmacogenetics of Alcohol and Alcohol Dependence Treatment","volume":"16","author":"Kranzler","year":"2010","journal-title":"Curr. Pharm. Des."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/FBP.0b013e3283242f05","article-title":"Genetics of dopamine receptors and drug addiction: A comprehensive review","volume":"20","author":"Gallo","year":"2009","journal-title":"Behav. Pharmacol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1093\/aje\/kwm281","article-title":"Meta-Analysis of the Association of the Taq1A Polymorphism with the Risk of Alcohol Dependency: A HuGE Gene-Disease Association Review","volume":"167","author":"Smith","year":"2007","journal-title":"Am. J. Epidemiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1080\/07853890310010014","article-title":"Genetics of alcohol and tobacco use in humans","volume":"35","author":"Tyndale","year":"2003","journal-title":"Ann. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"362937","DOI":"10.1155\/2014\/362937","article-title":"Understanding the Added Value of G-Protein-Coupled Receptor Heteromers","volume":"2014","author":"Franco","year":"2014","journal-title":"Scientifica"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1100\/tsw.2007.197","article-title":"Basic Concepts in G-Protein-Coupled Receptor Homo- and Heterodimerization","volume":"7","author":"Franco","year":"2007","journal-title":"Sci. World J."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"26016","DOI":"10.1074\/jbc.M710349200","article-title":"Identification of dopamine D1-D3 receptor heteromers: Indications for a role of synergistic D1-D3 receptor interactions in the striatum","volume":"283","author":"Marcellino","year":"2008","journal-title":"J. Biol. Chem."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"30308","DOI":"10.1074\/jbc.M102297200","article-title":"D2\/D3 Dopamine Receptor Heterodimers Exhibit Unique Functional Properties","volume":"276","author":"Scarselli","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"21377","DOI":"10.1073\/pnas.0903676106","article-title":"Calcium signaling cascade links do-pamine D1-D2 receptor heteromer to striatal BDNF production and neuronal growth","volume":"106","author":"Hasbi","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.bbrc.2010.12.083","article-title":"Dopamine D2 and D4 receptor heteromerization and its allosteric receptor\u2013receptor inter-actions","volume":"404","author":"Guidolin","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"8606","DOI":"10.1073\/pnas.150241097","article-title":"Dopamine D1 and adenosine A1 receptors form functionally interacting heteromeric complexes","volume":"97","author":"Hillion","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"18091","DOI":"10.1074\/jbc.M107731200","article-title":"Coaggregation, Cointernalization, and Codesensitization of Adenosine A2A Receptors and Dopamine D2Receptors","volume":"277","author":"Hillion","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1476-5381.2009.00152.x","article-title":"Marked changes in signal transduction upon heteromerization of dopamine D1 and histamine H3 receptors","volume":"157","author":"Ferrada","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.neuropharm.2008.05.008","article-title":"Inter-actions between histamine H3 and dopamine D2 receptors and the implications for striatal function","volume":"55","author":"Ferrada","year":"2008","journal-title":"Neuropharmacology"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"8570","DOI":"10.3390\/ijms15058570","article-title":"The G protein-coupled receptor heterodimer network (GPCR-HetNet) and its hub com-ponents","volume":"15","author":"Brito","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Gonzalez, S., Moreno-Delgado, D., Moreno, E., P\u00e9rez-Capote, K., Franco, R., Mallol, J., Cort\u00e9s, A., Casad\u00f3, V., Lluis, C., and Ortiz, J. (2012). Circadian-Related Heteromerization of Adrenergic and Dopamine D4 Receptors Modulates Melatonin Synthesis and Release in the Pineal Gland. PLoS Biol., 10.","DOI":"10.1371\/journal.pbio.1001347"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.neuropharm.2015.07.024","article-title":"Purinergic signaling in Parkinson\u2019s disease. Relevance for treatment","volume":"104","author":"Navarro","year":"2015","journal-title":"Neuropharmacology"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1212\/01.WNL.0000095206.44418.5C","article-title":"Receptor heteromerization in adenosine A2A receptor signaling: Relevance for striatal function and Parkinson\u2019s disease","volume":"61","author":"Fuxe","year":"2003","journal-title":"Neurology"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Zeppelin, T., Ladefoged, L.K., Sinning, S., Periole, X., and Schi\u00f8tt, B. (2018). A direct interaction of cholesterol with the dopamine transporter prevents its out-to-inward transition. PLoS Comput. Biol., 14.","DOI":"10.1371\/journal.pcbi.1005907"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/j.1471-4159.2012.07813.x","article-title":"Strong preferences of dopamine and l-dopa towards lipid head group: Importance of lipid composition and implication for neurotransmitter metabolism","volume":"122","author":"Grzybek","year":"2012","journal-title":"J. Neurochem."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuroscience.2019.04.056","article-title":"Dopamine Burden Triggers Cholesterol Overload Following Disruption of Synaptogenesis in Minimal Hepatic Encephalopathy","volume":"410","author":"Zhuge","year":"2019","journal-title":"Neuroscience"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.neulet.2013.09.003","article-title":"Oxysterols and Parkinson\u2019s disease: Evidence that levels of 24S-hydroxycholesterol in cerebrospinal fluid correlates with the duration of the disease","volume":"555","author":"Leoni","year":"2013","journal-title":"Neurosci. Lett."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1097\/WNR.0b013e32831578b2","article-title":"Regulation of \u03b1-synuclein expression by liver X receptor ligands in vitro","volume":"19","author":"Cheng","year":"2008","journal-title":"NeuroReport"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Schommer, J., Marwarha, G., Schommer, T., Flick, T., Lund, J., and Ghribi, O. (2018). 27-Hydroxycholesterol increases \u03b1-synuclein protein levels through proteasomal inhibition in human dopaminergic neurons. BMC Neurosci., 19.","DOI":"10.1186\/s12868-018-0420-5"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1111\/j.1471-4159.2011.07497.x","article-title":"The oxysterol 27-hydroxycholesterol regulates \u03b1-synuclein and tyrosine hy-droxylase expression levels in human neuroblastoma cells through modulation of liver X receptors and estrogen receptors--relevance to Parkinson\u2019s disease","volume":"119","author":"Marwarha","year":"2011","journal-title":"J. Neurochem."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/neup.12204","article-title":"Iso-pentenyl diphosphate isomerase, a cholesterol synthesizing enzyme, is localized in Lewy bodies","volume":"35","author":"Nakamura","year":"2015","journal-title":"Neuropathology"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"10129","DOI":"10.1523\/JNEUROSCI.0535-12.2012","article-title":"\u03b1-Synuclein inhibits intersynaptic vesicle mobility and maintains recycling-pool homeostasis","volume":"32","author":"Scott","year":"2012","journal-title":"J. Neurosci."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/1531-8249(199905)45:5<611::AID-ANA9>3.0.CO;2-X","article-title":"Increased susceptibility to sporadic Parkinson\u2019s disease by a certain combined alpha-synuclein\/apolipoprotein E genotype","volume":"45","author":"Kuhn","year":"1999","journal-title":"Ann. Neurol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1016\/j.bbamem.2011.06.017","article-title":"The fusogenic tilted peptide (67\u201378) of \u03b1-synuclein is a cholesterol binding domain","volume":"1808","author":"Fantini","year":"2011","journal-title":"Biochim. Biophys. Acta (BBA) Biomembr."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Hsiao, J.-H.T., Halliday, G.M., and Kim, W.S. (2017). \u03b1-Synuclein Regulates Neuronal Cholesterol Efflux. Molecules, 22.","DOI":"10.3390\/molecules22101769"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.peptides.2014.09.018","article-title":"Alpha synuclein is transported into and out of the brain by the blood\u2013brain barrier","volume":"62","author":"Sui","year":"2014","journal-title":"Peptides"},{"key":"ref_55","first-page":"132","article-title":"Brain neutral lipids mass is increased in \u03b1-synuclein gene-ablated mice","volume":"101","author":"Golovko","year":"2006","journal-title":"J. Neurochem."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1016\/j.febslet.2015.08.013","article-title":"Cholesterol facilitates interactions between \u03b1-synuclein oligomers and charge-neutral membranes","volume":"589","author":"Vetri","year":"2015","journal-title":"FEBS Lett."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.neulet.2016.02.042","article-title":"Effects of different isoforms of apoE on aggregation of the \u03b1-synuclein protein implicated in Parkinson\u2019s disease","volume":"618","author":"Emamzadeh","year":"2016","journal-title":"Neurosci Lett."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1194\/jlr.M300320-JLR200","article-title":"Changes in the levels of cerebral and extracerebral sterols in the brain of patients with Alzheimer\u2019s disease","volume":"45","author":"Heverin","year":"2004","journal-title":"J. Lipid Res."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1055\/s-2003-43053","article-title":"24S-Hydroxycholesterol: A Marker of Brain Cholesterol Metabolism","volume":"36","year":"2003","journal-title":"Pharmacopsychiatry"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s00401-021-02288-1","article-title":"Heterogeneity in \u03b1-synuclein fibril activity correlates to disease phenotypes in Lewy body dementia","volume":"141","author":"Sokratian","year":"2021","journal-title":"Acta Neuropathol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3233\/JAD-2010-101179","article-title":"Statins as Neuroprotectants: A Comparative In Vitro Study of Lipophilicity, Blood-Brain-Barrier Penetration, Lowering of Brain Cholesterol, and Decrease of Neuron Cell Death","volume":"23","author":"Sierra","year":"2011","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Yan, J., Xu, Y., Zhu, C., Zhang, L., Wu, A., Yang, Y., Xiong, Z., Deng, C., Huang, X.-F., and Yenari, M.A. (2011). Simvastatin Prevents Dopaminergic Neurodegeneration in Experimental Parkinsonian Models: The Association with Anti-Inflammatory Responses. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0020945"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/jnr.23329","article-title":"Simvastatin prevents neuroinflammation by inhibiting N-methyl-D-aspartic acid receptor 1 in 6-hydroxydopamine-treated PC12 cells","volume":"92","author":"Yan","year":"2014","journal-title":"J. Neurosci. Res."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"5856","DOI":"10.1073\/pnas.081620098","article-title":"Simvastatin strongly reduces levels of Alzheimer\u2019s disease beta-amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo","volume":"98","author":"Fassbender","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"5815","DOI":"10.1073\/pnas.081612998","article-title":"Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the -secretase ADAM 10","volume":"98","author":"Kojro","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1001\/archneur.57.10.1439","article-title":"Decreased Prevalence of Alzheimer Disease Associated With 3-Hydroxy-3-Methyglutaryl Coenzyme A Reductase Inhibitors","volume":"57","author":"Wolozin","year":"2000","journal-title":"Arch. Neurol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1001\/archneur.59.2.223","article-title":"Use of Lipid-Lowering Agents, Indication Bias, and the Risk of Dementia in Community-Dwelling Elderly People","volume":"59","author":"Rockwood","year":"2002","journal-title":"Arch. Neurol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1001\/archneur.62.7.1047","article-title":"Statin use and the risk of incident dementia: The Cardiovascular Health Study","volume":"62","author":"Rea","year":"2005","journal-title":"Arch. Neurol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"e2143","DOI":"10.1097\/MD.0000000000002143","article-title":"Early Statin Use and the Progression of Alzheimer Disease: A Total Population-Based Case-Control Study","volume":"94","author":"Lin","year":"2015","journal-title":"Medicine"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.bbr.2016.04.046","article-title":"Statin use and risk of Parkinson\u2019s disease: A meta-analysis","volume":"309","author":"Sheng","year":"2016","journal-title":"Behav. Brain Res."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/jnnp.2008.150433","article-title":"Statins are associated with a reduced risk of Alzheimer disease regardless of lipophilicity. The Rotterdam Study","volume":"80","author":"Haag","year":"2008","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/mds.26152","article-title":"Statins, plasma cholesterol, and risk of Parkinson\u2019s disease: A prospective study","volume":"30","author":"Huang","year":"2015","journal-title":"Mov. Disord."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1002\/mds.27006","article-title":"Statins may facilitate Parkinson\u2019s disease: Insight gained from a large, national claims database","volume":"32","author":"Liu","year":"2017","journal-title":"Mov. Disord."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Rozani, V., Giladi, N., El-Ad, B., Gurevich, T., Tsamir, J., Hemo, B., and Peretz, C. (2017). Statin adherence and the risk of Parkinson\u2019s disease: A population-based cohort study. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0175054"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"e14852","DOI":"10.1097\/MD.0000000000014852","article-title":"Effect of statins on Parkinson\u2019s disease: A systematic review and meta-analysis","volume":"98","author":"Yan","year":"2019","journal-title":"Medicine"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Bai, S., Song, Y., Huang, X., Peng, L., Jia, J., Liu, Y., and Lu, H. (2016). Statin Use and the Risk of Parkinson\u2019s Disease: An Updated Meta-Analysis. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0152564"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1212\/WNL.0b013e3181d6476a","article-title":"Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease: LEADe","volume":"74","author":"Feldman","year":"2010","journal-title":"Neurology"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1001\/archneur.62.5.753","article-title":"Atorvastatin for the treatment of mild to moderate Alzheimer disease: Preliminary results","volume":"62","author":"Sparks","year":"2005","journal-title":"Arch. Neurol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1017\/S1461145701002310","article-title":"Treatment with controlled-release lovastatin decreases serum con-centrations of human beta-amyloid (A beta) peptide","volume":"4","author":"Friedhoff","year":"2001","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1042\/CS20160382","article-title":"Hypercholesterolaemia and vascular dementia","volume":"131","author":"Appleton","year":"2017","journal-title":"Clin. Sci."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"3670","DOI":"10.1007\/s12035-016-9915-1","article-title":"Molecular Mechanisms of Vascular Dementia: What Can Be Learned from Animal Models of Chronic Cerebral Hypoperfusion?","volume":"54","author":"Du","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.3389\/fimmu.2017.01489","article-title":"The Cholinergic System Modulates Memory and Hippocampal Plasticity via Its Interactions with Non-Neuronal Cells","volume":"8","author":"Maurer","year":"2017","journal-title":"Front. Immunol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"300060520936177","DOI":"10.1177\/0300060520936177","article-title":"Dl-3-n-butylphthalide regulates cholinergic dysfunction in chronic cerebral hypoperfusion rats","volume":"48","author":"Sun","year":"2020","journal-title":"J. Int. Med. Res."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.neuron.2012.08.036","article-title":"Acetylcholine as a Neuromodulator: Cholinergic Signaling Shapes Nervous System Function and Behavior","volume":"76","author":"Picciotto","year":"2012","journal-title":"Neuron"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/S0165-6147(03)00195-0","article-title":"Novel insights into muscarinic acetylcholine receptor function using gene targeting technology","volume":"24","author":"Wess","year":"2003","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0893-133X(99)00146-3","article-title":"Nicotinic Receptors in the Brain Links between Molecular Biology and Behavior","volume":"22","author":"Picciotto","year":"2000","journal-title":"Neuropsychopharmacolohy"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1146\/annurev.psych.48.1.649","article-title":"Central Cholinergic Systems and Cognition","volume":"48","author":"Everitt","year":"1997","journal-title":"Annu. Rev. Psychol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.neulet.2004.01.004","article-title":"Activation of the intracerebral cholinergic nerve fibers originating in the basal forebrain increases regional cerebral blood flow in the rat\u2019s cortex and hippocampus","volume":"361","author":"Sato","year":"2004","journal-title":"Neurosci. Lett."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0736-5748(01)00017-X","article-title":"Regulation of regional cerebral blood flow by cholinergic fibers originating in the basal forebrain","volume":"19","author":"Sato","year":"2001","journal-title":"Int. J. Dev. Neurosci."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1042\/BST0341037","article-title":"Controlling inflammation: The cholinergic anti-inflammatory pathway","volume":"34","author":"Pavlov","year":"2006","journal-title":"Biochem. Soc. Trans."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0022-510X(77)90073-9","article-title":"Neurotransmitter enzyme abnormalities in senile dementia. Choline acetyltransferase and glutamic acid decarboxylase activities in necropsy brain tissue","volume":"34","author":"Perry","year":"1977","journal-title":"J. Neurol. Sci."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1159\/000239235","article-title":"Choline Acetyltransferase Activity in Vascular Dementia and Stroke","volume":"28","author":"Sharp","year":"2009","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/BF01271206","article-title":"Cerebrospinal fluid acetylcholine and choline in vascular dementia of Binswanger and multiple small infarct types as compared with Alzheimer-type dementia","volume":"103","author":"Tohgi","year":"1996","journal-title":"J. Neural. Transm."},{"key":"ref_94","first-page":"1161","article-title":"Differential acetylcholine and choline concentrations in the cerebrospinal fluid of patients with Alzheimer\u2019s disease and vascular dementia","volume":"117","author":"Jia","year":"2004","journal-title":"Chin. Med. J."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0006-8993(90)91561-T","article-title":"Substance P-like immunoreactivity, choline acetyltransferase activity and cholinergic muscarinic receptors in Alzheimer\u2019s disease and multi-infarct dementia","volume":"521","author":"Sakurada","year":"1990","journal-title":"Brain Res."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1017\/S0317167100037252","article-title":"Muscarinic Binding and Choline Acetyltransferase in Postmortem Brains of Demented Patients","volume":"13","author":"Waller","year":"1986","journal-title":"Can. J. Neurol. Sci. J. Can. Sci. Neurol."},{"key":"ref_97","first-page":"34","article-title":"Nicotinic receptors in de-mentia of Alzheimer, Lewy body and vascular types","volume":"176","author":"Court","year":"2000","journal-title":"Acta Neurol. Scand. Suppl."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.pharep.2019.01.012","article-title":"Chronic cerebral hypoperfusion-induced memory impairment and hippocampal long-term potentiation deficits are improved by cholinergic stimulation in rats","volume":"71","author":"Damodaran","year":"2019","journal-title":"Pharmacol. Rep."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"183340","DOI":"10.1016\/j.bbamem.2020.183340","article-title":"Pleiotropic effects of statins on brain cells","volume":"1862","author":"Sodero","year":"2020","journal-title":"Biochim. Biophys. Acta (BBA) Biomembr."},{"key":"ref_100","first-page":"5074","article-title":"Neuroprotective Effects of Simvastatin and Cilostazol in l-Methionine-Induced Vascular Dementia in Rats","volume":"54","author":"Galal","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S0002-9343(00)00353-3","article-title":"Effects of lovastatin on cognitive function and psychological well-being","volume":"108","author":"Muldoon","year":"2000","journal-title":"Am. J. Med."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1016\/S0140-6736(16)31357-5","article-title":"Interpretation of the evidence for the efficacy and safety of statin therapy","volume":"388","author":"Collins","year":"2016","journal-title":"Lancet"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.drudis.2020.01.003","article-title":"Current status and future prospects of pathophysiology-based neuroprotective drugs for the treatment of vascular dementia","volume":"25","author":"Sinha","year":"2020","journal-title":"Drug Discov. Today"},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Davoudian, P.A., and Wilkinson, S.T. (2020). Clinical Overview of NMDA-R Antagonists and Clinical Practice, Elsevier BV.","DOI":"10.1016\/bs.apha.2020.04.004"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1007S","DOI":"10.1093\/jn\/130.4.1007S","article-title":"Glutamate as a Neurotransmitter in the Brain: Review of Physiology and Pathology","volume":"130","author":"Meldrum","year":"2000","journal-title":"J. Nutr."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1002\/jnr.23426","article-title":"GluN2B N-methyl-D-aspartic acid receptor subunit mediates atorvastatin-Induced neuroprotection after focal cerebral ischemia","volume":"92","year":"2014","journal-title":"J. Neurosci. Res."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.coph.2006.08.013","article-title":"NMDA receptors and schizophrenia","volume":"7","author":"Kristiansen","year":"2007","journal-title":"Curr. Opin. Pharmacol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"11295","DOI":"10.1523\/JNEUROSCI.5612-10.2011","article-title":"Arrangement of Subunits in Functional NMDA Receptors","volume":"31","author":"Salussolia","year":"2011","journal-title":"J. Neurosci."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.neuroscience.2008.05.029","article-title":"Surface trafficking of N-methyl-d-aspartate receptors: Physiological and pathological perspectives","volume":"158","author":"Groc","year":"2009","journal-title":"Neuroscience"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0163-7258(02)00302-9","article-title":"The N-methyl-d-aspartate receptor subunit NR2B: Localization, functional properties, regulation, and clinical implications","volume":"97","author":"Loftis","year":"2003","journal-title":"Pharmacol. Ther."},{"key":"ref_111","first-page":"185","article-title":"Subunit arrangement and function in NMDA receptors","volume":"438","author":"Furukawa","year":"2005","journal-title":"Nat. Cell Biol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/S1474-4422(08)70165-0","article-title":"NMDA receptors in clinical neurology: Excitatory times ahead","volume":"7","author":"Kalia","year":"2008","journal-title":"Lancet Neurol."},{"key":"ref_113","first-page":"338","article-title":"Glutamate NMDA Receptors in Pathophysiology and Pharmacotherapy of Selected Nervous System Diseases","volume":"65","author":"Dobrek","year":"2011","journal-title":"PHMD"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nrn2153","article-title":"NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders","volume":"8","author":"Lau","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/aps.2009.24","article-title":"Molecular mechanisms of excitotoxicity and their relevance to pathogenesis of neurodegenerative diseases","volume":"30","author":"Dong","year":"2009","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1523\/JNEUROSCI.15-05-03318.1995","article-title":"Glutamate induces the production of reactive oxygen species in cultured forebrain neurons following NMDA receptor activation","volume":"15","author":"Reynolds","year":"1995","journal-title":"J. Neurosci."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1016\/S0140-6736(08)60694-7","article-title":"Emergency and Comprehensive Care for Stroke Needed","volume":"373","author":"Donnan","year":"2008","journal-title":"Lancet"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1161\/01.STR.0000153069.96296.fd","article-title":"Exciting, Radical, Suicidal: How Brain Cells Die after Stroke","volume":"36","author":"Lo","year":"2005","journal-title":"Stroke"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.pneurobio.2013.11.006","article-title":"Excitotoxicity and stroke: Identifying novel targets for neuroprotection","volume":"115","author":"Lai","year":"2014","journal-title":"Prog. Neurobiol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.neuroscience.2006.11.034","article-title":"Calcium-dependent NMDA-induced dendritic injury and MAP2 loss in acute hippocampal slices","volume":"145","author":"Hoskison","year":"2007","journal-title":"Neuroscience"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.1002\/jnr.22511","article-title":"P120 Catenin\/a N-Catenin Are Molecular Targets in the Neuroprotection and Neuronal Plasticity Mediated by Atorvastatin after Focal Cerebral Ischemia","volume":"88","author":"Jurado","year":"2010","journal-title":"J. Neurosci. Res."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1111\/j.1471-4159.2011.07171.x","article-title":"Glycogen synthase kinase-3 inhibition reduces ischemic cerebral damage, restores impaired mitochondrial biogenesis and prevents ROS production","volume":"116","author":"Valerio","year":"2011","journal-title":"J. Neurochem."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12916-019-1298-5","article-title":"Comparison of statins for secondary prevention in patients with ischemic stroke or transient ischemic attack: A systematic review and network meta-analysis","volume":"17","author":"Tramacere","year":"2019","journal-title":"BMC Med."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ahj.2018.12.007","article-title":"Comparative effectiveness and safety of statins as a class and of specific statins for primary prevention of cardiovascular disease: A systematic review, meta-analysis, and network meta-analysis of randomized trials with 94,283 participants","volume":"210","author":"Yebyo","year":"2019","journal-title":"Am. Hear. J."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.molmed.2007.11.004","article-title":"Pleiotropic effects of statin therapy: Molecular mechanisms and clinical results","volume":"14","author":"Wang","year":"2008","journal-title":"Trends Mol. Med."},{"key":"ref_126","first-page":"1","article-title":"Perspective of synaptic protection after post-infarction treatment with statins","volume":"13","year":"2015","journal-title":"J. Transl. Med."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"e3186","DOI":"10.1097\/MD.0000000000003186","article-title":"Early High-Dosage Atorvastatin Treatment Improved Serum Immune-Inflammatory Markers and Functional Outcome in Acute Ischemic Strokes Classified as Large Artery Atherosclerotic Stroke: A Randomized Trial","volume":"95","author":"Tuttolomondo","year":"2016","journal-title":"Medicine"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/jnc.12719","article-title":"Brain proteomics identifies potential simvastatin targets in acute phase of stroke in a rat embolic model","volume":"130","author":"Salvador","year":"2014","journal-title":"J. Neurochem."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1161\/STROKEAHA.108.531806","article-title":"Brain-Derived Neurotrophic Factor Contributes to Recovery of Skilled Reaching after Focal Ischemia in Rats","volume":"40","author":"Ploughman","year":"2009","journal-title":"Stroke"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.bbr.2008.03.020","article-title":"Molecularbiology of 5-HT receptors","volume":"195","author":"Hannon","year":"2008","journal-title":"Behav. Brain Res."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"107985","DOI":"10.1016\/j.neuropharm.2020.107985","article-title":"Median raphe serotonin neurons promote anxiety-like behavior via inputs to the dorsal hippocampus","volume":"168","author":"Abela","year":"2020","journal-title":"Neuropharmacology"},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"Rang, H.P., Dale, M.M., Ritter, J.M., Flower, R.J., and Henderson, G. (2012). Rang & Dale\u2019s pharmacology, Elsevier Churchill Livingstone. [7th ed.].","DOI":"10.1016\/B978-0-7020-3471-8.00001-9"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"e46464","DOI":"10.7554\/eLife.46464","article-title":"Molecular and anatomicalorganization of the dorsalraphenucleus","volume":"8","author":"Huang","year":"2019","journal-title":"Elife"},{"key":"ref_134","doi-asserted-by":"crossref","unstructured":"Borroto-Escuela, D.O., Ambrogini, P., Chru\u015bcicka, B., Lindskog, M., Crespo-Ramirez, M., Hern\u00e1ndez-Mondrag\u00f3n, J.C., Perez de la Mora, M., Schellekens, H., and Fuxe, K. (2021). The Role of Central Serotonin Neurons and 5-HT Heteroreceptor Complexes in the Pathophysiology of Depression: A HistoricalPerspective and Future Prospects. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22041927"},{"key":"ref_135","doi-asserted-by":"crossref","unstructured":"He, J., Hommen, F., Lauer, N., Balmert, S., and Scholz, H. (2020). Serotonin transporter dependent modulation of food-seeking behavior. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0227554"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.brainres.2015.10.044","article-title":"Circadianrhythms of clockgeneexpression in the cerebellum of serotonin-deficient Pet-1 knockout mice","volume":"1630","author":"Paulus","year":"2016","journal-title":"Brain Res."},{"key":"ref_137","doi-asserted-by":"crossref","unstructured":"Pourhamzeh, M., Moravej, F.G., Arabi, M., Shahriari, E., Mehrabi, S., Ward, R., Ahadi, R., and Joghataei, M.T. (2021). The Roles of Serotonin in Neuropsychiatric Disorders. Cell. Mol. Neurobiol., 1\u201322.","DOI":"10.1007\/s10571-021-01064-9"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"28901","DOI":"10.1074\/jbc.M602848200","article-title":"Subcellular Redistribution of the Serotonin Transporter by Secretory Carrier Membrane Protein 2","volume":"281","author":"Wiborg","year":"2006","journal-title":"J. Biol. Chem."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"e421","DOI":"10.1208\/aapsj070242","article-title":"Serotonin transporters: Implications for antidepressantdrug development","volume":"7","author":"White","year":"2005","journal-title":"AAPS J."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"114349","DOI":"10.1016\/j.bcp.2020.114349","article-title":"Serotonin transporter regulation by cholesterol-independent lipid signaling","volume":"183","author":"Deveau","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1124\/jpet.104.075028","article-title":"Chronic administration of statins altersmultiplegene expression patterns in mouse cerebral cortex","volume":"312","author":"Eckert","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/S2215-0366(20)30311-4","article-title":"Associations between statin use and suicidality, depression, anxiety, and seizures: A Swedish total-population cohort study","volume":"7","author":"Molero","year":"2020","journal-title":"Lancet Psychiatry"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"107625","DOI":"10.1016\/j.pharmthera.2020.107625","article-title":"Statins in the treatment of depression: Hype or hope?","volume":"215","author":"Otte","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1161\/01.CIR.103.15.1933","article-title":"Effect of hydroxymethylglutarylcoenzyme a reductase inhibitor therapy on high sensitive C-reactive protein levels","volume":"103","author":"Jialal","year":"2001","journal-title":"Circulation"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1001\/jama.289.13.1675","article-title":"Association of nitrotyrosinelevels with cardiovasculardisease and modulation by statintherapy","volume":"289","author":"Shishehbor","year":"2003","journal-title":"JAMA"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0735-1097(00)00771-3","article-title":"Simvastatininhibits the monocyteexpression of proinflammatorycytokines in patients with hypercholesterolemia","volume":"36","author":"Ferro","year":"2000","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_147","first-page":"687","article-title":"Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrinsite","volume":"6","author":"Welzenbach","year":"2001","journal-title":"Nat. Med."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1172\/JCI41384","article-title":"Statin-induced Kr\u00fcppel-like factor 2 expression in human and mouse T cells reduces inflammatory and pathogenic responses","volume":"120","author":"Bu","year":"2010","journal-title":"J. Clin. Investig."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1001\/jamapsychiatry.2017.0984","article-title":"Association of Microvascular Dysfunction With Late-Life Depression: A Systematic Review and Meta-analysis","volume":"74","author":"Houben","year":"2017","journal-title":"JAMA Psychiatry"}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/26\/10\/2838\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:59:05Z","timestamp":1760162345000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/26\/10\/2838"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,11]]},"references-count":149,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021,5]]}},"alternative-id":["molecules26102838"],"URL":"https:\/\/doi.org\/10.3390\/molecules26102838","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,11]]}}}